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Abstract The Wilms’ tumour suppressor gene (WT1) encodes
a zinc ¢nger-containing nuclear protein essential for kidney and
urogenital development. Initially considered a transcription fac-
tor, there is mounting evidence that WT1 has a role in post-
transcriptional processing. Using the interspecies heterokaryon
assay, we have demonstrated that WT1 can undergo nucleocy-
toplasmic shuttling. We have also mapped the region responsible
for nuclear export to residues 182^324. Our data add further
complexity to the role of WT1 in trancriptional and post-tran-
scriptional regulation.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The Wilms’ tumour suppressor gene (WT1) encodes a nu-
clear protein essential for kidney and urogenital development
[1]. WT1 contains four tandem C-terminal C2H2 zinc ¢ngers
(ZFs) [2,3] and structural modeling suggests that the N-termi-
nus contains an RNA recognition motif (RRM) [4]. There are
four major isoforms of WT1, ranging in size from 52 to 54
kDa, generated by alternate splicing of exon 5 and exon 9.
This results in variable insertion of a 17 amino acid sequence
near the middle of the protein and 3 amino acids (KTS) be-
tween ZFs 3 and 4. Isoform A lacks both splices while isoform
D contains both. Isoforms B and C contain either the 17
amino acid sequence or the KTS respectively [5]. Two nuclear
localisation sequences (NLSs) have been identi¢ed in the ZF
domain of WT1 [6], one in ZF 1 and another in ZF 2. This
was based on the ability of ZF 1 alone or ZFs 2 and 3, but
not ZFs 3 and 4, to direct L-galactosidase to the nucleus.
However, the precise residues that are required for nuclear
localisation have not been identi¢ed.
The high similarity of the WT1 ZFs to those of early
growth response gene 1 (EGR1) led to the assumption that
WT1 is a transcription factor [7]. Since then a number of
putative WT1 target genes have been identi¢ed for which
WT1 can act as a transcriptional activator or repressor [8].
However, these target genes have not been veri¢ed in vivo and
recent data suggests that few of the original target genes are
genuine [9]. There is also mounting evidence to suggest that
WT1 has a post-transcriptional role. This includes co-local-
isation of endogenous WT1 with splicing proteins in nuclear
speckles [10], binding of WT1 (particularly the C and D iso-
forms) to the splicing protein U2AF65 [11], enrichment of
WT1 by oligo dT chromatography [12], and in vitro binding
of all isoforms of WT1 to RNA [13].
Since a number of multifunctional regulatory proteins with
both transcriptional and post-transcriptional activity shuttle
between the nucleus and cytoplasm [14,15], we investigated
whether WT1 could be exported from the nucleus. We have
demonstrated that WT1 can shuttle between the nucleus and
cytoplasm and have identi¢ed the region of WT1 that con-
tains a nuclear export sequence (NES).
2. Materials and methods
2.1. Plasmid construction
Cloning of mouse WT1 A and D cDNAs has been described pre-
viously [16]. These cDNAs were subcloned into pcDNA3.1 (Invitro-
gen). To create the RRM mutant, the WT1 D cDNA was digested
with PpuMI and re-ligated, resulting in the deletion of the sequence
encoding amino acids 8^180. WT1v(182^324) was created by ampli-
¢cation and subsequent ligation of residues 1^181 and residues 325^
449. Other mutants were created by standard polymerase chain reac-
tion (PCR) techniques. To create Gal4 fusion constructs, PCR frag-
ments were subcloned into a vector derived from pSG424 that con-
tains the N-terminal 147 amino acids of Gal4 [17]. To generate
Rev1.4-green £uorescent protein (GFP) fusion constructs, WT1 con-
structs were subcloned into pRev(1.4)-GFP [18]. Rev-GFP [18] was
used as a control for leptomycin B (LMB)-sensitive export.
2.2. Cell culture and transfections
HEK 293T, NIH 3T3 and COS-7 cells were maintained in Dulbec-
co’s modi¢ed Eagle’s medium (Life Technologies) supplemented with
10% foetal calf serum (Life Technologies), 1% L-Gln (Life Technolo-
gies) and 1% penicillin^streptomycin (Life Technologies) in a 37‡C,
5% CO2 incubator.
2.3. Interspecies heterokaryon assay
Nucleocytoplasmic shuttling was assayed using a heterokaryon as-
say [19]. Human HEK 293T cells were transfected with expression
vectors, grown overnight and seeded with an equal number of murine
NIH 3T3 cells (2U104 cells/ml) in ¢bronectin-coated eight-well cham-
ber slides (Labtek). To determine whether endogenous WT1 could
shuttle, murine M15 cells were seeded with non-transfected human
HEK 293T cells that do not express WT1. After co-culturing for
3.5 h, cycloheximide (Calbiochem) was added to a ¢nal concentration
of 100 Wg/ml to inhibit protein synthesis. After a further 0.5 h, het-
erokaryons were formed by incubating the cells for 1 min with poly-
ethylene glycol (45% polyethylene glycol, 10% DMSO in HEPES bu¡-
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er, pH 7.4). Individual wells were washed with fresh medium, incuba-
ted with medium containing 100 Wg/ml of cycloheximide and cultured
for a further 4 h. When LMB was used, it was added to the cells 1 h
before fusion and for the remainder of the experiment at a concen-
tration of 10 ng/ml. Formation of heterokaryons was assessed using
phase contrast analysis to determine intact nuclear membranes, and
Hoechst staining to verify the presence of mouse and human nuclei.
For quanti¢cation, the ¢rst twenty heterokaryons seen on a slide were
counted as long as the nuclei were intact based on phase contrast
images. The £uorescence in the murine nucleus of a heterokaryon
containing the GFP-Rev mutant was used as the basis for assessing
whether active shuttling or di¡usion was taking place. Only hetero-
karyons in which active shuttling was taking place were counted as
shuttling. The standard error from two separate experiments was de-
termined.
2.4. Immuno£uorescence analysis
In most cases WT1 was detected using the mouse anti-WT1 6F-H2
monoclonal Ab (Dako), which binds to residues 1^181 of WT1, fol-
lowed by Alexa 594-conjugated anti-mouse IgG (Molecular Probes).
The RRM mutant was detected using the rabbit anti-WT1 C-19 poly-
clonal antibody (Santa Cruz), which binds to residues 431^450 of
WT1, followed by Cy3-conjugated anti-rabbit IgG. Hoechst 33258
(Sigma) was used to stain the nuclei.
3. Results
3.1. Both WT1 A and D can be exported out of the nucleus
To determine whether WT1 could be exported out of the
nucleus, we used the interspecies heterokaryon assay [19],
which is commonly used to assay protein export. Human
HEK 293T cells were transfected with an expression vector
for WT1 D (Fig. 1A) and then fused with murine NIH 3T3
cells to generate interspecies heterokaryons. Neither of these
cell lines express endogenous WT1. To identify heterokaryons,
cells were stained with Hoechst 33258. While human nuclei
appear di¡usely stained, mouse nuclei appear spotted (Fig.
1B). WT1 D was detected in the murine nucleus of a hetero-
karyon (Fig. 1B), indicating that WT1 D can be exported out
of the human nucleus and imported into the mouse nucleus.
Labelling of cellular proteins with 35S-Met and Cys demon-
strated e⁄cient blockage of protein synthesis by cyclohexi-
mide (Fig. 1C).
To con¢rm that shuttling of WT1 was not due to di¡usion,
cells were co-transfected with plasmids that express either
WT1 D or GFP fused to a Rev mutant (Rev1.4), which lacks
an NES [18]. In the same heterokaryon, shuttling of WT1 D
(52 kDa) but not the GFP-Rev1.4 mutant (40.5 kDa), was
observed (Fig. 1D). These data clearly demonstrate that
WT1 is actively exported from the nucleus.
A heterokaryon assay with WT1 A shows that it also shut-
tles from the human to the mouse nucleus (Fig. 1E), indicat-
ing that neither of the alternate splice sites contains an NES.
In addition, endogenous WT1 synthesised by the murine mes-
onephric M15 cell line was also shown to undergo nucleocy-
toplasmic shuttling (Fig. 1F), indicating that our data is phys-
iologically relevant.
3.2. Export of WT1 is not CRM1 dependent
CRM1 is an export receptor for several proteins with di-
verse cellular functions that are characterised by the presence
of a leucine-rich consensus sequence; LX(23)hXð23ÞLXL,
where X is any amino acid and h can be F, I, L, V or M
[20,21]. A similar leucine-rich sequence was identi¢ed between
residues 442 and 449 of WT1 (Fig. 2A). To determine whether
this sequence was a CRM1-binding NES, leucine residues 445,
447 and 449 were mutated to alanine residues. Heterokaryon
assays using this ‘NES mutant’ showed that the mutant pro-
tein was exported (Fig. 2B), indicating that the C-terminal
leucine-rich sequence was not responsible for CRM1-mediated
export. To con¢rm that export is not CRM1-mediated, the
heterokaryon assay was carried out in the presence of LMB,
which inhibits export via CRM1 [19]. The results in Fig. 2C
show that LMB did not inhibit export of WT1 D. However,
LMB inhibited export of GFP fused to Rev (Fig. 2D), which
is exported by CRM1 [20]. We concluded that the export of
WT1 is not CRM1 dependent.
3.3. The NES of WT1 is present between residues 182 and 324
To identify the location of the NES of WT1, we generated a
series of WT1 deletion mutants (Fig. 3A). These included a
series of C-terminal truncations (WT1 del ZF 4, WT1 del
ZF(3^4) and WT1 del ZF(2^4)) and a mutant in which the
N-terminal residues 8^180 were deleted. This mutant is re-
ferred to as the RRM mutant since it lacks the putative
RRM (amino acids 20^111) [4]. Western blot analyses of
WT1 D and the mutants generated are shown in Fig. 3B.
Fig. 1. Nucleocytoplasmic shuttling of WT1. A: Schematic represen-
tation of the WT1 A and D isoforms. B: Heterokaryon of an NIH
3T3 cell and a HEK 293T cell transfected with pcDNA3.1 WT1 D,
and visualised with Hoechst or a WT1 antibody as described in Sec-
tion 2. Human (h) and mouse (m) nuclei of heterokaryons are indi-
cated with arrows. C: Autoradiograph of an sodium dodecyl sulfate
gel containing total cell lysate from cells that were incubated with
35S-labelled Met and Cys in the presence or absence of cyclohexi-
mide (CHX). D: Heterokaryon with an NIH 3T3 cell and a HEK
293T cell co-expressing WT1 D and Rev1.4-GFP. E: Heterokaryon
of an NIH 3T3 cell and HEK 293T cell transfected with pcDNA3.1
WT1 A. F: Heterokaryon of an M15 cell and a HEK 293T cell.
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All four mutants were used in heterokaryon shuttling assays
(Fig. 3C). Deletion of N-terminal residues 8^180 had no e¡ect
on nucleocytoplasmic shuttling. Removal of ZFs 3^4 also did
not a¡ect shuttling. However, when ZF 2, was also deleted,
the protein was partially cytoplasmic. This demonstrates that
ZF 2 is required for e⁄cient nuclear localisation of WT1, but
precluded the use of the heterokaryon assay to study nuclear
export of this mutant.
To generate further C-terminal truncated proteins that were
nuclear localised, we generated a series of truncated WT1
proteins fused to the N-terminal 147 amino acids of Gal4
(Fig. 4A). This region of Gal4 contains an NLS that targets
Gal4 to the nucleus [22]. COS cells were transfected with these
constructs and the subcellular localisation of WT1 was exam-
ined (Fig. 4B). Gal4-WT1(1^181) was nuclear, however, Gal4-
WT1 del ZF(1^4) was partially cytoplasmic. This subcellular
distribution indicates the presence of an NES between resi-
Fig. 2. Determination of CRM1-dependent nucleocytoplasmic shut-
tling of WT1. A: Alignment of the C-terminal residues 442^449 of
WT1 D with the leucine-rich NES consensus sequence, h=hydro-
phobic amino acid. Leucine residues 445, 447 and 449 mutated to
alanine residues in the NES mutant are indicated in bold. B: Het-
erokaryons from an assay with the NES mutant. C: Heterokaryons
from an assay with WT1 D in the presence of LMB. Heterokaryons
were visualised as described in the legend to Fig. 1. D: Cells trans-
fected with pRev-GFP after incubation with or without LMB.
Fig. 3. Nucleocytoplasmic shuttling of WT1 mutants. A: Schematic
representation of WT1 deletion mutants. B: Western blot analysis
of WT1 and WT1 deletion mutants; 1, RRM mutant; 2, WT1; 3,
WT1 del ZF 4; 4, WT1 del ZF(3^4); 5, WT1 del ZF(2^4). C: Het-
erokaryons from assays with WT1 deletion mutants. Heterokaryons
were visualised as described in the legend to Fig. 1.
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dues 182 and 324, which can partially override the NLS of
Gal4. Surprisingly, Gal4-WT1 del ZF(2^4), which contains
the Gal4 NLS and one NLS of WT1, was also partially cyto-
plasmic. However, Gal4-WT1 del ZF(3^4) was nuclear. This
demonstrates the requirement for ZF 2 for e⁄cient nuclear
localisation in the presence of the presumptive NES. Western
blot analysis of the Gal4 fusion proteins (Fig. 4C) showed
that a higher fraction of Gal4-WT1 del ZF(1^4) and Gal4-
WT1 del ZF(2^4) was degraded compared with the other two
proteins. We surmise that this is due to partial cytoplasmic
localisation of these two proteins.
3.4. WT1 can mediate the export of Rev1.4-GFP
To unequivocally demonstrate that WT1 contains an NES,
and to con¢rm the location of the NES, we tested the ability
of WT1 and WT1 mutants to export GFP-Rev1.4, which
lacks an NES. We generated a series of Rev1.4-GFP fusion
proteins that contained either full length WT1 D, or the re-
gion containing the NES (WT1(182^324)) or WT1 without the
NES (WT1v(182^324)). These proteins are shown schemati-
cally in Fig. 5A. The proteins were used in interspecies het-
erokaron assays and representative heterokaryons from each
assay are shown in Fig. 5B. The percentage of heterokaryons
that could export, based on GFP £uorescence, was deter-
mined for each protein (Fig. 5C). While shuttling could be
detected in a few heterokaryons containing Rev1.4-GFP,
upon fusion to WT1, there was an increase in the number
of heterokaryons in which shuttling was detected. This was
increased further upon fusion of Rev1.4-GFP with WT1(182^
324). Again, this is consistent with the data in Fig. 4B and re-
iterates the role of ZF 2 in e⁄cient nuclear localisation in the
presence of an NES. As expected, upon deletion of residues
Fig. 4. Subcellular localisation of Gal4-WT1 fusion proteins in
COS-7 cells. A: Schematic representation of WT1 mutants fused to
Gal4. B: COS-7 cells expressing Gal4-WT1 fusion proteins were
immunostained with a WT1 antibody as described in Section 2.
C: Western blot analysis of Gal4-WT1 fusion proteins; 1, Gal4-
WT1(1^181); 2, Gal4-WT1 del ZF(1^4); 3, Gal4-WT1 del ZF(2^4);
4, Gal4-WT1 del ZF(3^4).
Fig. 5. Nucleocytoplasmic shuttling of Rev1.4-GFP-WT1 fusion
proteins. A: Schematic representation of WT1 and WT1 mutants
fused to Rev1.4-GFP. B: Heterokaryons from assays with Rev1.4-
GFP and WT1 fusion proteins. Heterokaryons were visualised as
described in the legend to Fig. 1. C: Western blot analysis of GFP
fusion proteins; 1, Rev1.4-GFP; 2, Rev1.4-WT1v(182^324)-GFP;
3, Rev1.4-WT1(182^324)-GFP; 4, Rev1.4-WT1-GFP. D: Graphical
representation of the percentage of heterokaryons in which protein
shuttling was detected; 1, Rev1.4-GFP; 2, Rev1.4-WT1-GFP;
3, Rev1.4-WT1(182^324)-GFP; 4, Rev1.4-WT1v(182^324)-GFP.
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182^324, the number of heterokaryons in which shuttling was
detected was decreased compared with that for the full length
WT1 fusion protein. We infer that the nuclear export activity
of WT1 is transferable to a protein that cannot export and is
localised to residues 182^324.
4. Discussion
Using the interspecies heterokaryon assay, we have shown
that both endogenous and recombinant WT1 can be exported
from a human nucleus and imported into a mouse nucleus.
We have demonstrated that in the same heterokaryon, WT1
shuttles while a known non-shuttling Rev1.4-GFP mutant
does not. We have also shown that the nuclear export activity
is transferable to a protein that lacks an NES. And ¢nally, we
have mapped the NES to residues 182^324 (Fig. 6). Mapping
of the NES was primarily based on the observation that Gal4-
WT1(1^181) (39 kDa) was nuclear while Gal4-WT1 del ZF(1^
4) and Gal4-WT1 del ZF(2^4) (57 and 61 kDa respectively)
were partially cytoplasmic. This is supported by data showing
that fusion of residues 182^324 to Rev1.4-GFP, which lacks
an NES, conferred nucleocytoplasmic shuttling.
The region of WT1 that the NES was localised to contains
a transcriptional activation domain as well as the alternately
spliced sequence encoded by exon 5. However, the latter is not
responsible for export since WT1 A, which lacks this se-
quence, is also exported. An analysis of the WT1 sequence
between 182 and 324 failed to identify any of the recently
identi¢ed non-classical export motifs [23^27]. This suggests
that WT1 contains a distinct, as yet unde¢ned, NES. In addi-
tion, export is not via CRM1, adding WT1 to the growing list
of proteins that are exported via unique export receptors
[23,25^27].
Although WT1 is exported, it does not accumulate in the
cytoplasm. Therefore, the protein does not appear to be se-
questered in the cytoplasm to regulate its nuclear activity un-
less this occurs under speci¢c physiological conditions. Based
on the heterokaryon assays, the protein is rapidly re-imported.
WT1 may play a role in the export of cargo from the nucleus.
The protein may shuttle in and out of the cell together with
hnRNPs, as observed for a number of hnRNP-associated pro-
teins [15,17]. This is consistent with data suggesting that WT1
has a post-transcriptional role [10^13]. WT1 may also play a
role in the export of nuclear co-activators such as FHL2 and
CBP with which it binds [28,29].
Nucleocytoplasmic shuttling of WT1 is directed by distinct
NES and NLS regions rather than a single signal. Our data is
in agreement with previous work showing that NLSs are
present in ZFs 1 and 2 [6] and we demonstrated the role of
ZF 2 in e⁄cient nuclear retention. Hence ZF 2 may be critical
for binding with a nuclear component, thus preventing nu-
clear export of WT1. This is consistent with gel ¢ltration
and sedimentation experiments, which have shown that nu-
clear WT1 is normally a part of a complex [12]. It is unlikely
that WT1 is retained in the nucleus by a direct interaction
with DNA or RNA since deletion of ZF 4, which strongly
reduced the binding of WT1 to DNA and RNA [13], had no
e¡ect on the nuclear localisation of WT1. Rather the protein
is likely to be retained in the nucleus by binding to other
proteins. The ZFs of WT1 have been shown to mediate bind-
ing to U2AF65, CBP, and par-4 [11,29,30], with ZFs 1 and 2
being critical for the interaction with CBP. The C-terminus of
WT1, which contains the ZFs, is also required for binding to
p53, WTAP and Ciao 1 [31^33]. Export may thus be depen-
dent on dissociation from WT1 binding factors and may ex-
plain why some heterokaryons expressing Rev1.4-GFP fused
to full length WT1 did not shuttle.
There was no di¡erence in the shuttling of WT1 A and D,
although when expressed alone, WT1 A co-localises predom-
inantly with transcription factors while WT1 D co-localises
more with nuclear speckles [10]. This is not surprising since
the isoforms interact via a self-association domain and can
form oligomers in vivo [34,35]. As all the isoforms can bind
RNA and both WT A and D are exported, this lends support
to the argument that the isoforms do not have independent
functions but rather interact together to e¡ect the role of WT1
in transcriptional and post-transcriptional control. Since splic-
ing takes place co-transcriptionally, co-ordination of these
two roles is quite likely.
In conclusion, we have shown that WT1 can undergo nu-
cleocytoplasmic shuttling and that an NES is present between
residues 182 and 324. Further research will be required to
establish the nature of the WT1 export complex and the na-
ture of the opposing ZF 2-mediated retention signal.
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